Nippon Fine Chemical held a briefing on its financial results for the second quarter of the fiscal year ending March 2027, explaining that functional oils for overseas markets had recovered as channel inventory adjustments unwound. The company expects full-year revenue and each profit measure to increase, forecasting higher revenue and profits.
Nippon Fine Chemical released an overview of its consolidated results for the second quarter of the fiscal year ending March 2027, explaining that functional oils for overseas markets had recovered as channel inventory adjustments unwound. During the period, overall revenue was slightly higher year on year, operating profit declined year on year, and net income increased.
In summary, revenue was ¥17.72 billion, operating profit was ¥2.65 billion, and interim net income attributable to owners of the parent was ¥2.68 billion, with earnings per share of ¥123.4. Compared with the published forecasts, revenue and profit were generally in line with plan, while interim net income was 11.5% above the published forecast.
The full-year outlook was unchanged, with revenue forecast at ¥37.4 billion, operating profit at ¥5.7 billion, and net income attributable to owners of the parent at ¥5.2 billion. The operating margin is expected to be 15.2%, and EBITDA is projected at ¥7.15 billion.
Capital investment of ¥5.23 billion is planned, mainly for construction of a plant for functional oils used in cosmetics. Construction of the new plant is scheduled to begin in April 2026, with operations targeted to commence in the first half of fiscal 2029.
Research and development expenses of ¥1.04 billion are budgeted for fiscal 2026, representing 2.8% of revenue. The company is also pursuing the commercial implementation of perovskite solar-cell materials and expanding its phospholipid technology business.